Upregulation of galectin-3 in relation to the severity of cardiomyopathy due to transgenic beta-adrenergic activation
30 August 2016 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker

Baker Heart and Diabetes Institute, Melbourne (Australia)
15 More presentations in this session
Access the full session
The Event
ESC Congress 2016
30 August 2016
08:30 CET
